Company Analysis
Sign in

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Nasdaq: CRBP · Pharmaceutical Preparations · Norwood, MA · filing with the SEC since 2014
Full chart Alerts Compare
Grade4.7
◀ Past 2.6● Present 5.1▶ Future 5.7
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

6 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Corbus Pharmaceuticals Holdings, Inc.’s names, not what it holds today.

Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
18
2 of them in 2025
Names they are printed under
2
a subsidiary
By yearGrantedApplications published
'16'17'18'19'20'21'22'23'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Corbus Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
17 published
Corbus Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
6 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jul 6, 202111,052,066Ultrapure tetrahydrocannabinol-11-oic acidsPharmaceuticalsCorbus Pharmaceuticals, Inc.
Aug 6, 201910,369,131Ultrapure tetrahydrocannabinol-11-oic acidsPharmaceuticalsCorbus Pharmaceuticals, Inc.
Dec 18, 201810,154,986Ultrapure tetrahydrocannabinol-11-oic acidsPharmaceuticalsCorbus Pharmaceuticals, Inc.
Oct 2, 201810,085,964Ultrapure tetrahydrocannabinol-11-oic acidsPharmaceuticalsCorbus Pharmaceuticals, Inc.
Nov 21, 20179,820,964Ultrapure tetrahydrocannabinol-11-oic acidsPharmaceuticalsCorbus Pharmaceuticals, Inc.
Oct 31, 20179,801,849Ultrapure tetrahydrocannabinol-11-oic acidsPharmaceuticalsCorbus Pharmaceuticals, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 7, 20252025/0248973CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOFPharmaceuticalsCorbus Pharmaceuticals, Inc.
Jun 19, 20252025/0195647ANTI-alpha-V-beta-8 INTEGRIN ANTIBODIES AND USES THEREOFPharmaceuticalsCorbus Pharmaceuticals, Inc.
Oct 26, 20232023/0339880COMPOSITIONS OF AJULEMIC ACID AND USES THEREOFPharmaceuticalsCorbus Pharmaceuticals, Inc.
Apr 21, 20222022/0117931ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDSPharmaceuticalsCorbus Pharmaceuticals, Inc.
Dec 30, 20212021/0401798LIPOXIN A4 ANALOGS AND USES THEREOFPharmaceuticalsCorbus Pharmaceuticals, Inc.
Sep 16, 20212021/0284621CANNABINOIDS AND USES THEREOFOrganic fine chemistryCorbus Pharmaceuticals, Inc.
Jul 1, 20212021/0198223METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOLOrganic fine chemistryCorbus Pharmaceuticals, Inc.
Dec 31, 20202020/0405687METHODS FOR THE TREATMENT OF INFECTIONPharmaceuticalsCorbus Pharmaceuticals, Inc.
Mar 26, 20202020/0093784ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDSPharmaceuticalsCorbus Pharmaceuticals, Inc. · patent 11,052,066 granted from it
May 9, 20192019/0133995METHODS FOR THE TREATMENT OF INFECTIONPharmaceuticalsCorbus Pharmaceuticals, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton CRBP · research, not advice